What are Gamna‑Gandy bodies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What are Gamna-Gandy Bodies?

Gamna-Gandy bodies are sclerosiderotic nodules composed of iron pigment (hemosiderin), calcium deposits, and dense fibrous tissue that form as a result of organized small hemorrhages.

Pathologic Composition and Formation

These structures represent dystrophic calcification that develops when chronic bleeding occurs in tissues. The nodules consist of:

  • Hemosiderin (iron pigment deposits)
  • Calcium salts encrusting collagenous fibers
  • Dense fibrous scar tissue
  • Fibrotic collagen

1 demonstrated through scanning electron microscopy that these bodies contain carbon (39%), oxygen (32%), iron (16%), phosphorus (7%), calcium (5%), and sodium (1%), with amorphous calcium phosphate identified on spectroscopy.

Classic Location and Associated Conditions

Traditionally, Gamna-Gandy bodies are most commonly found in the spleen, particularly in patients with:

  • Sickle cell disease (originally described in 1921) 2
  • Portal hypertension with congestive splenomegaly 3
  • Hemolytic anemia
  • Hereditary hemochromatosis
  • Acquired hemosiderosis

2 emphasizes that finding these bodies should alert clinicians to systemic disorders involving portal hypertension or congestive splenomegaly.

Expanding Recognition in Other Tissues

Recent evidence shows Gamna-Gandy bodies occur more broadly than historically recognized:

Cardiac myxomas: These bodies form linear arrays of mineral-encrusted fibers at the edges of resolving hemorrhages 4. They represent chronic microhemorrhages and may increase tumor friability and embolic risk 5.

Renal neoplasms: 6 found a 13% incidence (44/350 consecutive nephrectomies) in renal tumors, predominantly clear cell renal cell carcinoma (40/44 cases). They appeared intratumoral in 77% of cases, were associated with background fibrosis and hemosiderin-laden macrophages in 93%, and all tumors had cystic elements.

Other rare sites: CNS neoplasms 4, cutaneous tissue 1, lymph nodes, thymoma, and thyroid adenoma have been reported.

Critical Clinical Pitfall

A major diagnostic trap is mistaking Gamna-Gandy bodies for fungal organisms. 6 specifically notes that in 2 renal tumor specimens, extensive fungal workups were performed because the structures were not recognized as Gamna-Gandy bodies. 4 explains the historical context: these bodies were initially thought to be fungal infections in the early 20th century due to "bamboo-like and articulated" fibers that mimicked mycelia forms—a notion disproven in the 1930s.

Microscopic Recognition

The structures appear as:

  • Spheroidal yellow-brown foci
  • Pale-yellow to brown, refractile material
  • Often associated with organizing hematomas
  • Background hemosiderin-laden macrophages and fibrosis
  • Size typically ranging from 0.2 to 7 mm (mean 1.7 mm) 6

Awareness of their characteristic morphologic appearance is crucial to avoid unnecessary infectious disease workups and misdiagnosis 6.

References

Research

Splenic nodules at autopsy.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 2013

Research

Expansively splenic reflective foci: A case-based résumé.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2025

Research

Gamna-Gandy bodies in surgical neuropathology specimens: observations and a historical note.

Journal of neuropathology and experimental neurology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.